|
In
my humble opinion, it would be slighly naive to underestimate
the importance of market economics when one looks at the
Paxil story. The links here will provide you with some insight
into the huge numbers involved.
Remember
that one way of protesting GlaxoSmith Kline's business practices
is to simply dump their stock. Check your portfolios
and mutual funds and vote with your dollars. Judging
by the number of class action suits filed against them,
this might turn out to be quite a prudent move for medium
term investors.
Shoul
anyone come across any other topical link or information,
I would gladly include
it here
|
